Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000049632 | SCV000486854 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2016-08-23 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000049632 | SCV001406890 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-09-15 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 56221). This sequence change creates a premature translational stop signal (p.Met388Ilefs*36) in the AIRE gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AIRE are known to be pathogenic (PMID: 11524731, 26141571). This variant is present in population databases (rs386833672, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with autoimmune polyendocrinopathy syndrome (PMID: 9398840, 18708298, 28919897). This variant is also known as an A insertion at the position 1284. For these reasons, this variant has been classified as Pathogenic. |
National Institute of Allergy and Infectious Diseases - |
RCV000049632 | SCV004036174 | pathogenic | Polyglandular autoimmune syndrome, type 1 | 2023-09-14 | criteria provided, single submitter | clinical testing | |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000049632 | SCV000082039 | probable-pathogenic | Polyglandular autoimmune syndrome, type 1 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. |